Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson’s disease patients

Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease

(2012) Maria Björkqvist et al.   PLoS One

Central Role of the EGF Receptor in Neurometabolic Aging

(2012) Sana Siddiqui et al.   International Journal of Endocrinology

Long-term effects of cytokine treatment on cognitive behavioral recovery and neuronal regeneration in soman-poisoned mice

(2011) Jean-Marc Collombet et al.   BEHAVIOURAL BRAIN RESEARCH

Heparin-binding EGF-like growth factor is required for synaptic plasticity and memory formation

(2011) Atsushi Oyagi et al.   BRAIN RESEARCH

Mild Cognitive Impairment in Parkinson’s Disease

(2011) Dag Aarsland et al.   Current Neurology and Neuroscience Reports

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

(2010) Alice S. Chen-Plotkin et al.   ANNALS OF NEUROLOGY

Is quality of life in non-demented Parkinson’s disease patients related to cognitive performance? A clinic-based cross-sectional study

(2010) N. Klepac et al.   EUROPEAN JOURNAL OF NEUROLOGY

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

(2009) Caroline H. Williams-Gray et al.   BRAIN

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

(2009) Josef Marksteiner et al.   NEUROBIOLOGY OF AGING

Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF

(2009) G. C. O'Keeffe et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA